3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Prostatic Neoplasms
4
Uterine Cervical Neoplasms
3
Ganglioneuroblastoma
3
Sarcoma, Ewing
2
Precursor Cell Lymphoblastic Leukemia-Lymphoma
2
Neuroblastoma
2
Vaginal Neoplasms
1
Stomach Neoplasms
1
Stage I Prostate Adenocarcinoma AJCC v7
1
Squamous Cell Carcinoma of Head and Neck
1
Polycystic Ovary Syndrome
1
Oropharyngeal Neoplasms
1
Multiple Myeloma
1
Locally Advanced Cervical Adenocarcinoma
1
Infertility
1
Human Papillomavirus-Negative Neck Squamous Cell Carcinoma
1
Cholangiocarcinoma
1
Cervical Adenocarcinoma
1
Carcinosarcoma
1
Carcinoma, Hepatocellular
1
Breast Neoplasms
1
Biochemically Recurrent Prostate Carcinoma
1
Adenocarcinoma Of Esophagus
1
Interventions
Magnetic Resonance Spectroscopy
9
Cyclophosphamide
7
X-Rays
6
Temozolomide
6
Specimen Handling
6
Phantoms, Imaging
6
Biopsy
6
Nuclear Medicine Department, Hospital
5
Etoposide
5
Nivolumab
4
Bevacizumab
4
Radiation
3
Irinotecan
3
Automobiles
3
ulixertinib
2
tipifarnib
2
tazemetostat
2
selpercatinib
2
palbociclib
2
olaparib
2
lutetium Lu 177 dotatate
2
larotrectinib
2
ivosidenib
2
etoposide phosphate
2
erdafitinib
2
ensartinib
2
abemaciclib
2
Watchful Waiting
2
Radiotherapy
2
ONC206
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Ependymoma
×
Congresses as Topic
×
1 year
×
Clear all
No trials found.